Jacobs Levy Equity Management
QTTB icon

Jacobs Levy Equity Management’s Q32 Bio QTTB Stock Holding History

Jacobs Levy Equity Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-34,844
Closed -$120K – 1217
2024
Q4 		$120K Buy
+34,844
New +$1.1M ﹤0.01% 914
2023
Q2 		– Sell
-11,025
Closed -$204K – 1097
2023
Q1 		$204K Buy
11,025
+7,066
+178% +$176K ﹤0.01% 905
2022
Q4 		$89.8K Sell
3,959
-545
-12% -$14.5K ﹤0.01% 927
2022
Q3 		$131K Sell
4,504
-179
-4% -$7.3K ﹤0.01% 953
2022
Q2 		$166K Sell
4,683
-21,853
-82% -$746K ﹤0.01% 967
2022
Q1 		$1.45M Sell
26,536
-19,847
-43% -$1.23M 0.01% 690
2021
Q4 		$3.04M Sell
46,383
-2,095
-4% -$203K 0.02% 530
2021
Q3 		$6.87M Sell
48,478
-7,813
-14% -$995K 0.05% 370
2021
Q2 		$7.37M Buy
56,291
+22,726
+68% +$2.84M 0.05% 358
2021
Q1 		$5.68M Buy
33,565
+6,294
+23% +$1.33M 0.04% 398
2020
Q4 		$5.54M Buy
27,271
+3,458
+15% +$668K 0.05% 378
2020
Q3 		$4.59M Buy
23,813
+6,564
+38% +$1.47M 0.05% 361
2020
Q2 		$4.72M Buy
+17,249
New +$4.6M 0.05% 350

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Jacobs Levy Equity Management's QTTB Position: Q1 2025 in Review

Jacobs Levy Equity Management sold out of Q32 Bio (QTTB) in Q1 2025, closing a stake of 34,844 shares — an estimated $120K sold.

Jacobs Levy Equity Management first reported a position in QTTB in Q2 2020 and held it in 13 quarters. The position peaked at $7.37M in Q2 2021. 73 funds tracked by Wall St. Rank hold QTTB as of Q1 2025.

  • Jacobs Levy Equity Management reported no remaining Q32 Bio position as of Q1 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 34,844 Q32 Bio shares in Q1 2025, an estimated $120K.
  • Jacobs Levy Equity Management first reported a position in Q32 Bio in Q2 2020 and held it in 13 quarters.
  • Jacobs Levy Equity Management's Q32 Bio position peaked at $7.37M in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2025, filed 15 May 2025.